Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.84	101.21	67.6	45.16	291.06	39.05
Short-Term Investments	314.68	318.79	284.37	143.56	-	-
Cash & Short-Term Investments	382.52	420	351.97	188.71	291.06	39.05
Cash Growth	16.83%	19.33%	86.51%	-35.16%	645.46%	131.80%
Accounts Receivable	2.04	3.68	5.88	-	-	-
Other Receivables	2.5	1.8	1.7	0.6	-	-
Receivables	4.54	5.48	7.58	0.6	-	-
Prepaid Expenses	16.13	14.16	10.22	20.56	7.64	0.9
Other Current Assets	-	0.4	-	-	-	-
Total Current Assets	403.19	440.04	369.77	209.88	298.7	39.95
Property, Plant & Equipment	79.1	82.05	92.68	33.02	6.26	3.04
Other Long-Term Assets	4.19	4.23	6.74	9.16	0.87	0.54
Total Assets	486.48	526.32	469.19	252.06	305.83	43.53
Accounts Payable	2.19	4.26	3.28	5.99	0.71	1.6
Accrued Expenses	6.7	12.3	10.32	7.15	5.53	1.64
Current Portion of Leases	6.51	7.56	7.91	8.41	-	-
Current Income Taxes Payable	0.8	0.67	4.02	-	-	-
Current Unearned Revenue	1.35	13.65	132.26	-	-	-
Other Current Liabilities	0.88	1.04	1	0.43	0.49	0.12
Total Current Liabilities	18.43	39.48	158.8	21.97	6.72	3.36
Long-Term Leases	50.49	51.65	60.32	17.53	-	-
Long-Term Unearned Revenue	0.3	6.51	7.72	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.4	-
Total Liabilities	69.22	97.64	226.83	39.5	7.12	3.36
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	563.51	558.06	437.13	402.89	392.38	1.02
Retained Earnings	-146.69	-129.34	-194.97	-188.29	-93.67	-42.51
Comprehensive Income & Other	0.44	-0.04	0.2	-2.06	-	-
Total Common Equity	417.26	428.68	242.36	212.55	298.72	-41.49
Shareholders' Equity	417.26	428.68	242.36	212.55	298.72	40.17
Total Liabilities & Equity	486.48	526.32	469.19	252.06	305.83	43.53
Total Debt	57	59.21	68.23	25.94	-	-
Net Cash (Debt)	325.52	360.79	283.74	162.78	291.06	39.05
Net Cash Growth	24.73%	27.16%	74.31%	-44.08%	645.46%	131.80%
Net Cash Per Share	8.02	9.25	8.59	5.20	46.44	35.33
Filing Date Shares Outstanding	35.26	35.63	32.33	33.08	31.25	1.41
Total Common Shares Outstanding	35.25	35.61	32.17	31.39	31.22	1.24
Working Capital	384.76	400.56	210.98	187.9	291.98	36.59
Book Value Per Share	11.84	12.04	7.53	6.77	9.57	-33.35
Tangible Book Value	417.26	428.68	242.36	212.55	298.72	-41.49
Tangible Book Value Per Share	11.84	12.04	7.53	6.77	9.57	-33.35
Machinery	18.96	18.42	15.26	8.54	6.12	2.16
Construction In Progress	0.09	-	-	0.58	-	-
Leasehold Improvements	1.93	1.93	1.86	1.86	1.56	1.25

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q